Marco Allinovi

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 91 publications

Clinical utility of copeptin in histiocytosis-associated arginine vasopressin deficiency: a report of three cases.

Clinical utility of copeptin in histiocytosis-associated arginine vasopressin deficiency: a report of three cases.

Journal: Annals of hematology

Published: April 16, 2026

Potential Mechanisms of Partial/Transient Response or Resistance to Daratumumab Therapy: A Focus on Anti-Daratumumab Antibodies and Urinary Daratumumab Loss.

Potential Mechanisms of Partial/Transient Response or Resistance to Daratumumab Therapy: A Focus on Anti-Daratumumab Antibodies and Urinary Daratumumab Loss.

Journal: Antibodies (Basel, Switzerland)

Published: April 08, 2026

Case Report: Ureteral obstruction reveals rare underlying fibro-inflammatory, infiltrative, and proliferative disorders: report of four cases.

Case Report: Ureteral obstruction reveals rare underlying fibro-inflammatory, infiltrative, and proliferative disorders: report of four cases.

Journal: Frontiers in immunology

Published: March 08, 2026

Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplant.

Multicenter cohort analysis of cardiac amyloidosis patients treated with heart transplant.

Journal: Revista espanola de cardiologia (English ed.)

Published: January 19, 2026

Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.

Anti-podocin and Anti-KIRREL1 Antibodies and Steroid Resistance, FSGS, and Disease Recurrence after Transplantation in Autoimmune Podocytopathies.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 07, 2026

Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study.

Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study.

Journal: Rheumatology (Oxford, England)

Published: November 30, 2025

Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy.

Zebra bodies recognition by artificial intelligence (ZEBRA): a computational tool for Fabry nephropathy.

Journal: Scientific reports

Published: November 06, 2025

Potential implications of subclinical hypervolemia, identified by a multiparametric approach, in causing left ventricular hypertrophy in clinically euvolemic children on dialysis: a prospective longitudinal pilot study.

Potential implications of subclinical hypervolemia, identified by a multiparametric approach, in causing left ventricular hypertrophy in clinically euvolemic children on dialysis: a prospective longitudinal pilot study.

Journal: Pediatric nephrology (Berlin, Germany)

Published: November 04, 2025

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: September 25, 2025

Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.

Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.

Journal: Rheumatology (Oxford, England)

Published: September 13, 2025

Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update

Anti-rituximab antibodies in autoimmune diseases and hematologic malignancies: An update

Journal: La Revue de medecine interne

Published: September 03, 2025

Kidney Outcomes in ANCA-Glomerulonephritis According to Induction Immunosuppression and Histopathology.

Kidney Outcomes in ANCA-Glomerulonephritis According to Induction Immunosuppression and Histopathology.

Journal: Kidney international reports

Published: August 12, 2025

Showing 1-12 of 91

Last Updated: 09/26/2026